These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12005425)

  • 1. SUMO wrestling with specificity.
    VanDemark AP; Hill CP
    Structure; 2002 Mar; 10(3):281-2. PubMed ID: 12005425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
    Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
    Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a substrate recognition site on Ubc9.
    Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
    J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tag-team SUMO wrestling.
    Duda DM; Schulman BA
    Mol Cell; 2005 Jun; 18(6):612-4. PubMed ID: 15949435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1.
    Macauley MS; Errington WJ; Okon M; Schärpf M; Mackereth CD; Schulman BA; McIntosh LP
    J Biol Chem; 2004 Nov; 279(47):49131-7. PubMed ID: 15355965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
    Giraud MF; Desterro JM; Naismith JH
    Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO/sentrin: protein modifiers regulating important cellular functions.
    Kretz-Remy C; Tanguay RM
    Biochem Cell Biol; 1999; 77(4):299-309. PubMed ID: 10546893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
    Tatham MH; Chen Y; Hay RT
    Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New structural clues to substrate specificity in the "ubiquitin system".
    Hochstrasser M
    Mol Cell; 2002 Mar; 9(3):453-4. PubMed ID: 11931752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport.
    Pichler A; Melchior F
    Traffic; 2002 Jun; 3(6):381-7. PubMed ID: 12010456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular targeting of proteins by sumoylation.
    Wilson VG; Rangasamy D
    Exp Cell Res; 2001 Nov; 271(1):57-65. PubMed ID: 11697882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the road to repair: PCNA encounters SUMO and ubiquitin modifications.
    Matunis MJ
    Mol Cell; 2002 Sep; 10(3):441-2. PubMed ID: 12408814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
    Werner A; Flotho A; Melchior F
    Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
    Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue.
    Lee GW; Melchior F; Matunis MJ; Mahajan R; Tian Q; Anderson P
    J Biol Chem; 1998 Mar; 273(11):6503-7. PubMed ID: 9497385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
    Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
    Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
    Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.